Company profile for Mandos Health

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Mandos Health is a biopharmaceutical company committed to furthering the development of VTS-270 for Niemann-Pick Type C, an ultra-rare genetic disease that affects the body’s ability to metabolize cholesterol and lipids within cells. Niemann-Pick Type C disease can affect the brain, nerves, liver, spleen, bone marrow, and lungs and there are currently no FDA-approved treatments.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Los Angeles, CA
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251009444024/en/Data-Analyses-Show-Benefit-for-Individuals-With-Infantile-Onset-Niemann-Pick-Disease-Type-C-Treated-With-Investigational-Drug-Adrabetadex

BUSINESSWIRE
09 Oct 2025

https://www.businesswire.com/news/home/20250912494253/en/Mandos-Health-to-Present-New-Analyses-in-Niemann-Pick-Disease-Type-C-at-the-2025-American-Neurological-Association-Annual-Meeting

BUSINESSWIRE
12 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty